The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, saying it unfairly lumped failed drugs with two recently approved treatments.
Health
·
Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness
CN
CitrixNews Staff
Originally reported by New York Times. Read the full story at the original source.
Related Articles
Health
The Guardian view on listening to people with learning disabilities: a matter of life and death | Editorial
The Covid pandemic shed an unforgiving light on health and social care inequalities. The lessons have yet to be absorbed...
CitrixNews Staff
·
2 hours ago
Health
At risk in-person postpartum mums' groups saved
Image caption, The Happy Mums Foundation was set up in Carlisle in 2015Published44 minutes agoA mothers' support se...
CitrixNews Staff
·
3 hours ago
Health
Cancer patients 'deteriorating' due to staff shortages, radiologists warn
Image source, Getty ImagesByGarry OwenBBC WalesPublished10 minutes agoCancer patients have warned delays in scans could ...
CitrixNews Staff
·
4 hours ago
Health
The truth about testicles: are we facing spermageddon?
When it comes to fertility, testosterone and reproductive fitness, manosphere misinformation is rife - which can lead to...
CitrixNews Staff
·
5 hours ago